I agree that this site is using cookies. You can find further informations here.
X
Lee, Eudocia Quant
175  results:
Search for persons X
?
1

Leptomeningeal metastases from solid tumors: A SNO and ASCO..:

Wilcox, Jessica A ; Chukwueke, Ugonma N ; Ahn, Myung-Ju...
Neuro-Oncology.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Phase 2 study of pembrolizumab in patients with recurrent a..:

Brastianos, Priscilla K. ; Kim, Albert E. ; Giobbie-Hurder, Anita...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
3

Neurologic complications of oncologic therapy:

, In: Handbook of Neuro-Oncology Neuroimaging,
Budhu, Joshua A. ; Wen, Patrick Y. ; Lee, Eudocia Quant - p. 131-155 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Contributors:

, In: Handbook of Neuro-Oncology Neuroimaging,
Baehring, Joachim M. ; Bastos, Dhiego C.A. ; Beegle, Richard... - p. xix-xxiii , 2022
Link: https://doi.org/10.1016/..
 
?
5

CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ..:

Rahman, Rifaquat ; Trippa, Lorenzo ; Lee, Eudocia Quant...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi68-vi69 , 2021
Link: https://doi.org/10.1093/..
 
?
6

Activity of PD-1 blockade with nivolumab among patients wit..:

Bi, Wenya Linda ; Nayak, Lakshmi ; Meredith, David M...
Neuro-Oncology.  24 (2021)  1 - p. 101-113 , 2021
Link: https://doi.org/10.1093/..
 
?
7

INNV-40. REAL WORLD INTEGRATION OF THE NEUROLOGIC ASSESSMEN..:

Lim-Fat, Mary Jane ; Allen, Marie ; Smith, Timothy...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi114-vi114 , 2021
Link: https://doi.org/10.1093/..
 
?
8

IMMU-02. GENOMIC AND TRANSCRIPTOMIC CORRELATES OF IMMUNOTHE..:

Alvarez-Breckenridge, Christopher ; Prakadan, Sanjay ; Markson, Samuel...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi92-vi92 , 2021
Link: https://doi.org/10.1093/..
 
?
9

Phase 2 trial of hypoxia activated evofosfamide (TH302) for..:

Brenner, Andrew J. ; Floyd, John ; Fichtel, Lisa...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
10

BIOM-30. BLOOD COUNTS THROUGH TREATMENT COURSE IN NEWLY DIA..:

Deng, Davy ; Hammoudeh, Lubna ; Cagney, Daniel...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi17-vi17 , 2021
Link: https://doi.org/10.1093/..
 
?
11

PATH-16. EVALUATION OF SEX-BASED DIFFERENCES IN CLINICAL OU..:

Shi, Diana ; Lim-Fat, Mary Jane ; Nassar, Amin...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi118-vi118 , 2021
Link: https://doi.org/10.1093/..
 
?
12

INNV-27. AN INNOVATIVE VIRTUAL MULTI-INSTITUTIONAL, MULTIDI..:

Rogers, James ; Acquaye, Alvina ; Ikiddeh-Barnes, Ukeme...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi111-vi111 , 2021
Link: https://doi.org/10.1093/..
 
?
13

CTIM-30. PHASE II TRIAL OF PEMBROLIZUMAB IN RECURRENT AND R..:

Brastianos, Priscilla ; Kim, Albert ; Giobbie-Hurder, Anita...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi57-vi57 , 2021
Link: https://doi.org/10.1093/..
 
?
14

Phase II study of ipilimumab and nivolumab in leptomeningea..:

Brastianos, Priscilla K. ; Strickland, Matthew R. ; Lee, Eudocia Quant...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
15

CTIM-02. PHASE II STUDY OF IPILIMUMAB AND NIVOLUMAB IN LEPT..:

Strickland, Matthew ; Lee, Eudocia Quant ; Wang, Nancy...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi49-vi49 , 2021
Link: https://doi.org/10.1093/..
 
1-15